{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:19:09Z","timestamp":1784546349254,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001735","name":"Weizmann Institute of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00403","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T04:41:58Z","timestamp":1584420118000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance"],"prefix":"10.3389","volume":"11","author":[{"given":"Debby","family":"Reuveni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Aricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam C.","family":"Souroujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1212\/WNL.0b013e3182377fa6","article-title":"Myasthenia gravis with antibodies to MuSK: another step toward solving mystery?","volume":"77","author":"Evoli","year":"2011","journal-title":"Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","article-title":"Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury","volume":"15","author":"Valenzuela","year":"1995","journal-title":"Neuron"},{"key":"B3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for Agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1242\/dev.038711","article-title":"To build a synapse: signaling pathways in neuromuscular junction assembly","volume":"137","author":"Wu","year":"2010","journal-title":"Development"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1196\/annals.1254.057","article-title":"A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score","volume":"998","author":"Sanders","year":"2003","journal-title":"Ann N Y Acad Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"Diaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0165-2478(99)00092-9","article-title":"Mucosal tolerance","volume":"69","author":"Weiner","year":"1999","journal-title":"Immunol Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41577-018-0002-x","article-title":"To respond or not to respond - a personal perspective of intestinal tolerance","volume":"18","author":"Mowat","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1172\/JCI8121","article-title":"Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment","volume":"104","author":"Im","year":"1999","journal-title":"J Clin Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1003810030414","article-title":"Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis","volume":"111","author":"Im","year":"2000","journal-title":"J Neuroimmunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1749-6632.1996.tb21134.x","article-title":"Oral tolerance in myasthenia gravis","volume":"778","author":"Drachman","year":"1996","journal-title":"Ann N Y Acad Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am J Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1523\/JNEUROSCI.19-09-03376.1999","article-title":"Constitutively active MuSK is clustered in the absence of agrin and induces ectopic postsynaptic-like membranes in skeletal muscle fibers","volume":"19","author":"Jones","year":"1999","journal-title":"J Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1096\/fj.05-4909fje","article-title":"Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor","volume":"20","author":"Aricha","year":"2006","journal-title":"FASEB J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Expert Rev Clin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/79792","article-title":"Natural killer cells determine the outcome of B cell-mediated autoimmunity","volume":"1","author":"Shi","year":"2000","journal-title":"Nat Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1089\/jir.2016.0112","article-title":"Innate immune cytokines, fibroblast phenotypes, and regulation of extracellular matrix in lung","volume":"37","author":"Richards","year":"2017","journal-title":"J Interferon Cytokine Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J Autoimmun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/nyas.13591","article-title":"An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients","volume":"1413","author":"Adolfo","year":"2018","journal-title":"Ann N Y Acad Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J Autoimmun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/mi.2012.4","article-title":"Oral tolerance to food protein","volume":"5","author":"Pabst","year":"2012","journal-title":"Mucosal Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.7520605","article-title":"Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis","volume":"265","author":"Chen","year":"1994","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jaut.2016.10.001","article-title":"Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain","volume":"76","author":"Kuhn","year":"2017","journal-title":"J Autoimmun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0155082","DOI":"10.1371\/journal.pone.0155082","article-title":"Oral tolerance induction in experimental autoimmune encephalomyelitis with candida utilis expressing the immunogenic MOG35-55 peptide","volume":"11","author":"Buerth","year":"2016","journal-title":"PLoS ONE"},{"key":"B29","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1073\/pnas.96.14.8086","article-title":"Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit","volume":"96","author":"Barchan","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1073\/pnas.89.1.421","article-title":"Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering","volume":"89","author":"Miller","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/eji.1830230426","article-title":"Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin","volume":"23","author":"Melamed","year":"1993","journal-title":"Eur J Immunol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.147.7.2155","article-title":"Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy","volume":"147","author":"Whitacre","year":"1991","journal-title":"J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00403\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T18:31:21Z","timestamp":1695925881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00403\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2020.00403"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00403","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"article-number":"403"}}